| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |